NCT07315490

Brief Summary

Endotracheal Tube (ETT) is frequently used for GA (general anesthesia) to deliver oxygen and volatile anesthetic agents to the patient and serves as a channel for anesthetic gases. The ETT cuff helps in positive pressure ventilation and maintains an adequate seal between the endotracheal tube and trachea. Prolonged inflation of ETT cuff can cause ischemic changes of tracheal mucosa and other complications like postoperative sore throat (POST), hoarseness of voice, difficulty in swallowing, tracheal wall ulcer, stricture etc. Among these, the occurrence of sore throat after GA ranges from 21 - 65% Hence it important to measure ETT cuff pressure in intubated patients. The reliable and convenient way for this is using an ETT manometer, which is not readily available in most of hospitals in Pakistan.Many studies have focused on incidence of POST. Most of these studies have been done in western population and differences in various ethnicities are well reported . In Pakistan, air is widely used for ETT cuff inflation. If the results depict minimal cuff pressure changes and postoperative side effects with Xylocaine as compared to air, then it can be inferred that cuff pressure does not increase due to N2O when Xylocaine is used, hence, it can be safely used for cuff inflation eliminating the requirement of ETT cuff pressure monitoring and also the ETT cuff manometer, serving as a cost-effective alternative.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Aug 2025

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 2, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 5, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 2, 2026

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2026

Completed
Last Updated

January 2, 2026

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

December 5, 2025

Last Update Submit

December 23, 2025

Conditions

Keywords

Endotacheal TubeGeneral AnesthesiaAirETT cuffXylocainePost operative sore throatETT cuff ManometerCoughSore throatHoarseness of voiceIntra cuff pressure

Outcome Measures

Primary Outcomes (2)

  • Measurement of ETT cuff Pressure

    Patients will be divided in 2 groups on basis of the medium used for ETT cuff infalation (Air or Xylocaine) and intracuff pressure will be measured using ETT cuff manometer immediately after intubation, at 5min, 15min, 30min and then eveey 30 min till completion of surgery

    From the time of intubation till extubation

  • Postoperative Sorethroat, Cough and Hoarseness

    This will be measured immediately after extubation, at 30min, 6hrs and 24 hours postoperative using POST (postoperative sorethroat) scoring scale for both groups of subjects and responses will be compared. Sorethroat (grade 0-3; where 0 stand for no sorethroat and 3 stand for severe sorethroat) Cough (grade 0-3; where 0 stand for no cough and 3 stand for severe cough) Hoarseness of Voice (grade 0-3; where 0 stand for no hoarseness and 3 stand for severe hoarseness)

    From extubation till 24 hours postoperatively

Secondary Outcomes (1)

  • Demographic data

    From enrollment till 24 hours postoperatively

Study Arms (2)

Xylocaine

EXPERIMENTAL

In 50% of subjects undergoing surgeriws under GA, Xylocaine will be used for ETT cuff inflation. Intracuff pressures will be measured every 15 mins using ETT cuff manometer and compared with intracuff air.Postoperative POST scoring will be done to study its effect on postopertaive sorethroat and incidence will weighed against intracuff air.

Drug: Xylocaine

Air

PLACEBO COMPARATOR

In 50% of subjects undergoing surgeries under GA, air will be ussed for ETT cuff inflation, intracuff pressures will be measured every 15 min POST scoring will be done postoperatively.

Drug: Xylocaine

Interventions

In patients undergoing surgeries under GA, xylocaine will be used for 50% subjects and ETT cuff pressures will be measured at regular and compated to air to study if using xylocaine can abolish the affect of Nitrous oxide on intracuff air pressure. Also postoperatively, POST scoring will be done.

AirXylocaine

Eligibility Criteria

Age13 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • ASA (American Society of Anaesthesiologists) I and II
  • Male/Female
  • Age group 18 - 55 years
  • Patient undergoing surgery under general anesthesia.
  • Patients undergoing surgery in supine/ Trendelenburg position.

You may not qualify if:

  • ASA III and IV
  • Patients with preoperative history of cough or sore throat
  • Patients undergoing nose, throat, or airway surgery.
  • Patients with history of allergic diseases
  • Patient with known pulmonary disease
  • Patients in whom more than 1 attempt on intubation is done
  • Patients who may need postoperative ventilation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Liaquat

Islamabad, Federal Capital, 44800, Pakistan

Location

Related Links

MeSH Terms

Conditions

CoughHoarsenessPharyngitis

Interventions

Lidocaine

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsVoice DisordersLaryngeal DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesRespiratory Tract InfectionsInfectionsPharyngeal DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Post Graduate Trainee, Department of Anesthesiology, PAEC general hospital Islamabad

Study Record Dates

First Submitted

December 5, 2025

First Posted

January 2, 2026

Study Start

August 2, 2025

Primary Completion

January 20, 2026

Study Completion

January 20, 2026

Last Updated

January 2, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations